Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Schentag

Showing results (151-160 of 236) with videos related to

Pageof 24
Sort By:
Annals of Internal Medicine|April 1, 1977
Intravenous theophylline therapy: nomogram guidelinesW J Jusko, J R Koup, J W Vance, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1983
Steady-state moxalactam pharmacokinetics in patients: noncompartmental versus two-compartmental analysisD J Swanson, D P Reitberg, I L Smith, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysisD P Reitberg, D A Marble, R W Schultz, et al.
Drug Intelligence & Clinical Pharmacy|February 1, 1985
A rapid, universal TI-59 model-independent pharmacokinetic analysis program based on statistical moment theoryD P Reitberg, I L Smith, S J Love, et al.
Archives of Internal Medicine|October 1, 1989
Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradicationC A Peloquin, T J Cumbo, D E Nix, et al.
Journal of Clinical Pharmacology|February 1, 1995
The effect of verapamil on the nephrotoxic potential of gentamicin as measured by urinary enzyme excretion in healthy volunteersD J Kazierad, G J Wojcik, D E Nix, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study GroupC H Ballow, R N Jones, D M Johnson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 1999
Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibilityR P Rifenburg, J A Paladino, S M Bhavnani, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacaeW C Chan, R C Li, J M Ling, et al.
Lancet (London, England)|January 27, 1979
Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusionJ J Schentag, F B Cerra, G Calleri, et al.
Pageof 24

Showing results (151-160 of 236) with videos related to

Sort By:
Pageof 24
Annals of Internal Medicine|April 1, 1977
Intravenous theophylline therapy: nomogram guidelinesW J Jusko, J R Koup, J W Vance, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1983
Steady-state moxalactam pharmacokinetics in patients: noncompartmental versus two-compartmental analysisD J Swanson, D P Reitberg, I L Smith, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysisD P Reitberg, D A Marble, R W Schultz, et al.
Drug Intelligence & Clinical Pharmacy|February 1, 1985
A rapid, universal TI-59 model-independent pharmacokinetic analysis program based on statistical moment theoryD P Reitberg, I L Smith, S J Love, et al.
Archives of Internal Medicine|October 1, 1989
Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradicationC A Peloquin, T J Cumbo, D E Nix, et al.
Journal of Clinical Pharmacology|February 1, 1995
The effect of verapamil on the nephrotoxic potential of gentamicin as measured by urinary enzyme excretion in healthy volunteersD J Kazierad, G J Wojcik, D E Nix, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 1997
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study GroupC H Ballow, R N Jones, D M Johnson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 1999
Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibilityR P Rifenburg, J A Paladino, S M Bhavnani, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacaeW C Chan, R C Li, J M Ling, et al.
Lancet (London, England)|January 27, 1979
Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusionJ J Schentag, F B Cerra, G Calleri, et al.
Pageof 24